The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.
Click on the button below to create your account and get immediate access to thousands of articles.
Pharma, Kedrion and BPL together to conquer the US and China
The Tuscan Group led by Paolo Marcucci will create, together with Britain's BPL, one of the fastest-growing companies in the plasma sector, a global player in human plasma-derived medicinal products. Pivot of the deal are Permira funds and Ugo di Francesco, CEO of Chiesi
September27,2022
Fosun partners with Kite Pharm to bring T-cell therapy to China
Shanghai Fosun Pharmaceutical announced strategic cooperation, including establishment of a cooperative enterprise in China, with Kite Pharma, through its wholly owned subsidiary to introduce T-cell therapy of Kite Pharma for lymphoma patients.
January18,2017
If you have any questions, please enter them in the box below.
Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.
Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.
